title: VolitionRx begins first ovarian cancer detection study.
authors.affiliation: Chief Scientific Officer, VolitionRx, Belgian Volition SA, Rue du Séminaire 20A, Namur BE-5000, Belgium.
authors.forename: Jake
authors.initials: J
authors.lastname: Micallef
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D001798:Blood Proteins / Q000032:analysis; D019295:Computational Biology; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000097:blood* / Q000473:pathology*; D010865:Pilot Projects
chemical_list: D014408:Biomarkers, Tumor; D001798:Blood Proteins